tiprankstipranks
Can-Fite BioPharma Ltd. (IL:CANF)
:CANF
Israel Market

Can Fite Bio (CANF) Income Statement

Compare
0 Followers

Can Fite Bio Income Statement

Last quarter (Q4 2023), Can Fite Bio's total revenue was $155.00K, a decrease of -21.32% from the same quarter last year. In Q4, Can Fite Bio's net income was $-1.65M. See Can Fite Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 743.00K$ 810.00K$ 853.00K$ 763.00K$ 2.03M
Gross Profit
$ 743.00K$ 810.00K$ 853.00K$ 763.00K$ 2.03M
Operating Expenses
$ 8.94M$ 10.91M$ 13.70M$ 14.90M$ 14.04M
Depreciation and Amortization
$ 15.00K$ 14.00K$ 14.00K$ 12.00K$ 14.00K
EBITDA
$ -8.18M$ -10.08M$ -12.83M$ -14.13M$ -11.99M
Operating Income
$ -8.20M$ -10.10M$ -12.84M$ -14.14M$ -12.01M
Other Income/Expenses
$ 561.00K$ -77.00K$ 227.00K$ -304.00K$ -618.00K
Pretax Income
$ -7.63M$ -10.17M$ -12.62M$ -14.44M$ -12.63M
Net Income
$ -7.63M$ -10.53M$ -12.60M$ -14.81M$ -13.05M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.01$ -0.01$ -0.02$ -0.04$ -0.15
Diluted EPS
$ -0.01$ -0.01$ -0.02$ -0.04$ -0.15
Weighted Average Shares Outstanding
1.28B 815.75M 553.08M 358.41M 85.91M
Weighted Average Shares Outstanding (Diluted)
1.28B 815.75M 553.08M 358.41M 85.91M
Currency in USD

Can Fite Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis